Drug Trial Radar · NCT03094416
Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors
Last checked: Nov 20, 2026Latest source record: Apr 5, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
66
Actual
Start
Jul 30, 2018
Primary completion
Jun 15, 2020
Study completion Jun 15, 2020
Sponsor
- Lead sponsor
- IBSA Institut Biochimique SAIndustry
- Sponsor type
- Industry
- First posted
- Mar 29, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label therapeutic efficacy study of Tirosint (levothyroxine sodium) capsules in thyroidectomized patients taking proton pump inhibitors and levothyroxine, evaluating changes in serum levels of Thyroid Stimulating Hormone (TSH) upon switch to Tirosint with respect to baseline.
Conditions
- Hypothyroidism;Postablative
Interventions
levothyroxine sodium capsuleDrug
after the run-in period, patients will be switched to levothyroxine sodium capsule at the same dose used during run-in
Proton pump inhibitor (PPI)Drug
for the whole study duration all subjects will keep taking their proton pump inhibitor medication, as per prescription and as before inclusion
Levothyroxine Sodium (LT4) TabletsDrug
during the run-in period, subjects will continue taking their levothyroxine sodium tablet medication as per prescription and as before inclusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Thyroid Stimulating Hormone (TSH)Time frame: baseline and 12 weeks
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
California Head and Neck Specialists
La Jolla, California
Coastal Metabolic Research Centre
Ventura, California
Washington Hospital Center
Washington D.C., District of Columbia
MedStar Union Memorial Hospital
Baltimore, Maryland
NYC Health + Hospitals/ Queens
New York, New York
Diabetes & Endocrinology Consultants, PC
Morehead City, North Carolina
Carolina Ear Nose and Throat Clinic
Orangeburg, South Carolina
Virginia Commonwealth University
Richmond, Virginia
Stonesifer Endocrine Care & Clinical Research Inc., PS
Federal Way, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.